Enliven Therapeutics
ELVN
#5629
Rank
C$1.26 B
Marketcap
$25.80
Share price
-1.37%
Change (1 day)
6.10%
Change (1 year)

EPS for Enliven Therapeutics (ELVN)

EPS in 2023 (TTM): -$2.07

According to Enliven Therapeutics's latest financial reports the company's current EPS (TTM) is -$2.12. In 2021 the company made an earnings per share (EPS) of -$0.83 a decrease over its 2020 EPS that were of -$0.64.

EPS history for Enliven Therapeutics from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$2.07
2021-$0.8330.44%
2020-$0.64